Skip to content

Journal of Pharmaceutical Sciences

ISSN 0022-3549

9 papers in the library · 152 citations · publishing 1975-2012

Papers

Sort Most recent Most cited

Microdosing: A Critical Assessment of Human Data

Journal of Pharmaceutical Sciences August 23, 2012 Malcolm Rowland 51 citations

Ultrasensitive analytical methodologies have now made possible the ability to characterize the pharmacokinetics (PK) of compounds following administration to humans of a minute, subpharmacologic dose, a microdose. This has the potential to provide pre-IND information to help in early candidate selection, but only if such information is reasonably predictive of PK at pharmacologic doses. The...

Ibogaine labeling with 99mTc-tricarbonyl: synthesis and transport at the mouse blood-brain barrier.

Journal of Pharmaceutical Sciences December 1, 2009 Nicolas Tournier, Pascal André, Sandy Blondeel et al. 14 citations

The (99m)Tc-tricarbonyl core may be used as an ideal tool for gamma-labeling ligands in noninvasive SPECT imaging. However, most (99m)Tc-tricarbonyl-labeled agents have difficulty crossing the blood-brain barrier (BBB). We radiolabeled the neuroactive indole ibogaine with (99m)Tc-tricarbonyl and measured its transport into the mouse brain by in situ brain perfusion. We measured the interactions...

Synthesis and Action on the Central Nervous System of Mescaline Analogues Containing Piperazine or Homopiperazine Rings

Journal of Pharmaceutical Sciences March 1, 1983 Michal W. Majchrzak, A Kotełko, Roman Guryn et al. 5 citations

Structural juxtaposition of the 3,4,5-trimethoxyphenyl group in the same molecule with a piperazine or homopiperazine ring has been realized in a series of mescaline analogues (I-IV) as part of an investigation into the pharmacological properties of the seven-membered perhydro-1,4-diazepines (homopiperazines). The analogous six-membered piperazines were synthesized and tested as reference...

GLC-mass Spectral Determination of Mescaline in Plasma of Rabbits after Intravenous Injection

Journal of Pharmaceutical Sciences 1980 C. Van Peteghem, A. Heyndrickx, W. Van Zele 11 citations

A GLC-mass spectral analysis with a deuterated internal standard was developed to measure plasma mescaline concentrations after intravenous administration to rabbits. The drug and the internal standard were extracted with benzene, derivatized with trifluoroacetic acid anhydride, and chromatographed on 2.5% QF-1 with mass fragmentographic detection. The detection limit is 5 ng/ml of plasma. The...

Molecular Connectivity Analysis of Hallucinogenic Mescaline Analogs

Journal of Pharmaceutical Sciences July 1, 1979 Richard A Glennon, Lemont B. Kier, Alexander T. Shulgin 29 citations

The hallucinogenic (psychotomimetic) potency of 10 mescaline analogs was examined by molecular connectivity analysis. Potencies could be described by a two-term relating equation, which explained 94% of the variance in activity, on the basis of structural variation, 2,5-Dimethoxy substitution as well as the nature of the 4-position substituent played an important role in determining...

Actions of Mescaline on Isolated Rat Atria

Journal of Pharmaceutical Sciences July 1, 1977 Peter K. S. Siegl, Raymond F. Orzechowski 2 citations

Mescaline, in concentrations of 5 x 10(-4) and 1 x 10(-3) M, produced negative chronotropic and positive inotropic responses in isolated, spontaneously beating rat atria. In tissues driven at a constant rate, the inotropic response was diminished greatly, indicating that the increment in the force of contraction was secondary to the reduction in rate. These chronotropic and inotropic responses...

GLC-Mass Spectral Analysis of Psilocin and Psilocybin

Journal of Pharmaceutical Sciences May 1, 1977 David B. Repke, Dale Thomas Leslie, Daniel Mandell et al. 31 citations

With the combined technique of GLC-mass spectrometry, psilocin and psilocybin, two hallucinogenic indoles, were analyzed as their trimethylsilyl derivatives. The method was applied to these two components in an extract of Psilocybe cubensis (Earle) Sing.

Synthesis of Potential Mescaline Antagonists

Journal of Pharmaceutical Sciences October 1, 1976 F. Jun. Desantis, Karl A. Nieforth 4 citations

1-[2-(3,4,5-Trimethoxyphenyl)ethyl]-3-pyrroline, 2-(3,4,5-trimethoxybenzyl)-1,2,3,6-tetrahydropyridine, N-n-propylmescaline, N-cyclopropylmethylmescaline, and N-allylmescaline were synthesized as potential mescaline antagonists. The ability of these compounds to antagonize mescaline-induced disruption of swim behavior is also given.